盛夏
Lv3
370 积分
2022-12-12 加入
-
Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis
5个月前
已完结
-
A phase I study assessing the safety and tolerability of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849 +10kb C->T
5个月前
已完结
-
Three-year efficacy, safety, and tolerability outcomes from a phase 3 study of a low-dose copper intrauterine device
5个月前
已关闭
-
Real-World Use of Semaglutide for Weight Management: Patient Characteristics and Dose Titration—A Danish Cohort Study
6个月前
已完结
-
The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
8个月前
已完结
-
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
8个月前
已完结
-
Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
9个月前
已完结
-
Semaglutide improves cardiovascular health independently of weight loss
9个月前
已完结
-
Oral Immunotherapy
9个月前
已完结
-
IL-1 in Aging and Pathologies of Hematopoietic Stem Cells
9个月前
已完结